(1R)-1-[2-(benzyloxy)phenyl]ethan-1-amine hydrochloride

Compound number
MolPort-027-845-337
CAS number
123982-91-2
IUPAC
(1R)-1-[2-(benzyloxy)phenyl]ethan-1-amine hydrochloride
IUPAC traditional
(1R)-1-[2-(benzyloxy)phenyl]ethanamine hydrochloride
SMILES
Cl.C[C@@H](N)c1ccccc1OCc1ccccc1 |r|
InChI key
MGOKOLBJBKBTSX-UTONKHPSSA-N
Molecular formula
Molecular weight
263.77
Solubility
not available

Marketplace Offers

BLD Pharmatech (made-to-order)

Direct S&H to USA 90.00 USD Direct S&H to World: 95.00 USD
Catalog
Building blocks
Ships out
25 business days
Purity
95%
Last updated
this week
In warehouse
Unverified

Supplier Catalogue Data

Pack size Ships out Price Quantity
1 g August 11, 2022 615.00 USD
Add to Cart Buy

MedChemExpress (made-to-order)

Direct S&H to USA 50.00 USD Direct S&H to World: 85.00 USD
Catalog
Building blocks
Ships out
20 business days
Purity
>98%
Last updated
this month
In warehouse
Unverified

Supplier Catalogue Data

Pack size Ships out Price Quantity
25 mg August 4, 2022 268.32 USD
Add to Cart Buy
50 mg August 4, 2022 375.39 USD
Add to Cart Buy
100 mg August 4, 2022 558.57 USD
Add to Cart Buy

Get your compounds in the right format

MolPort Reweighting and Reformatting Services

More Information

Compound identifiers

Compound number
MolPort-027-845-337
CAS number
123982-91-2

Names, Synonyms and 3rd Party Identifiers

Name
(1R)-1-[2-(benzyloxy)phenyl]ethan-1-amine hydrochloride
MFCD12756868

InChI

InChI
1/C15H17NO.ClH/c1-12(16)14-9-5-6-10-15(14)17-11-13-7-3-2-4-8-13;/h2-10,12H,11,16H2,1H3;1H/t12-;/m1./s1
InChI key
MGOKOLBJBKBTSX-UTONKHPSSA-N

Formula

Molecular formula
C15H18ClNO
Molecular weight
263.77

MolPort Guarantee

When you purchase products through the MolPort website from any seller other than MolPort itself, you will be protected by the MolPort Guarantee. If you purchase products from MolPort itself, this MolPort Guarantee will not apply, and your remedies will be governed by the MolPort Terms of Sale and Supply.

We use cookies to improve your experience on our websites and for advertising. By clicking "Accept All", you consent to our use of cookies. Learn more

Feedback